BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 14, 2008
View Archived Issues
Avastin Improves PFS Again in Phase III Breast Cancer Trial
A Phase III trial of Avastin (bevacizumab) in breast cancer met its primary endpoint of improving progression-free survival (PFS), but analysts remained split on whether the new data would be enough to gain FDA approval. (BioWorld Today)
Read More
Inspire's Denufosol Starts 2nd Phase III Study in Cystic Fibrosis
Read More
Vertex Offerings Expected to Raise up to $405.8M
Read More
Panel: Good Communication Cuts Dangers of Shareholder Activism
Read More
Genzyme Barely Misses; Posts Strong Fourth-Quarter Sales
Read More
Clinic Roundup
Read More
Other News To Note
Read More